Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 8165458, 2 pages
https://doi.org/10.1155/2017/8165458
Editorial

NRF2 as an Emerging Therapeutic Target

1MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool L69 3GE, UK
2Division of Cancer Research, School of Medicine, University of Dundee, Dundee DD1 9SY, UK
3Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA
4Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA
5Reata Pharmaceuticals Inc., 2801 Gateway Drive, Irving, TX 75063, USA

Correspondence should be addressed to Ian M. Copple

Received 21 December 2016; Accepted 22 December 2016; Published 31 January 2017

Copyright © 2017 Ian M. Copple et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This article has no abstract.